Vir Biotechnology, Inc. (VIR)

Vir Biotechnology, Inc. (VIR) is a healthcare company (biotechnology) based in the United States. The share price is $9.25, down 3.44% on the day, which values the company at $1.72B. Price as of 18 Nov 2026, 11:36 UTC, from Yahoo Finance.

Key facts

Share price
$9.25−3.44% today
Market value
$1.72B
Funk Score
22/100
Against its own history
Well above its usual priceusual price $6.78
200-week average
$10.5913% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Vir Biotechnology, Inc. in more detail

VIR trades at -3.9× next year's expected earnings, 5.7× sales. Measured against its own history, the price is 36% above what its usual multiples would imply ($6.78) — well above its usual price. It sits 13% below its 200-week average of $10.59.

Over the last five fiscal years Vir Biotechnology, Inc. has compounded revenue -2.7% a year. Its Funk Score is 22 out of 100 (financial strength 4.9, profitability 0.4, growth 2.7, value 0.8, each out of 10).

In its favour: More cash than debt. Worth checking: Altman Z in the distress zone; Weak Piotroski score.

Vir Biotechnology, Inc. (VIR): questions and answers

What is Vir Biotechnology, Inc.'s market cap?

Vir Biotechnology, Inc. is valued at $1.72B at a share price of $9.25.

Is VIR overvalued or undervalued?

Against its own history, VIR is well above its usual price: the price is 36% above the $6.78 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is VIR above its 200-week moving average?

No. VIR is 12.6% below its 200-week average of $10.59. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Vir Biotechnology, Inc. growing?

Over the last five fiscal years Vir Biotechnology, Inc.'s revenue grew -2.7% a year.

Does VIR pay a dividend?

Vir Biotechnology, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Vir Biotechnology, Inc. (VIR) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/VIR

Underlying data: Yahoo Finance; company filings with the SEC.